Workflow
生命科学医药
icon
Search documents
中国生物科技服务(08037)拟向富策控股发行本金总额为3500万美元的可转换债券
智通财经网· 2025-12-29 23:45
Group 1 - The company has entered into a subscription agreement with Fucai Holdings to issue convertible bonds totaling $35 million (approximately HKD 272.3 million) [1] - The initial conversion price is set at HKD 0.66 per share, which could lead to the issuance of up to 412.6 million shares, representing approximately 42.28% of the total shares currently issued [1] - If the conversion rights are fully exercised, the total issued share capital will increase by approximately 29.72%, assuming no changes in the company's issued capital from the announcement date until conversion [1] Group 2 - The board believes that the subscription will strengthen the company's capital base and prepare for long-term development and improved financial status [2] - Issuing convertible bonds will not cause immediate dilution of existing shareholders' equity [2] - The company sees the issuance of convertible bonds as an opportunity to expand and strengthen its capital base while attracting new investors to broaden its shareholder base [2]